한국미생물·생명공학회지 (Microbiology and Biotechnology Letters)

  • 제50권3호
  • /
  • Pages.422-429
  • /
  • 2022
  • /
  • 1598-642X(pISSN)
  • /
  • 2234-7305(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Hepatitis C Virus Genotypes and RNA Quantitative Values in Cheonan, Korea from 2007 to 2016

  • Bishguurmaa, Renchindorj (Department of Laboratory Medicine, Graduate School, Dankook University) ;
  • Bo Kyeung, Jung (Department of Laboratory Medicine, College of Medicine, Dankook University) ;
  • Joowon, Park (Department of Laboratory Medicine, College of Medicine, Dankook University)
  • 투고 : 2022.05.09
  • 심사 : 2022.07.22
  • 발행 : 2022.09.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The hepatitis C virus (HCV) genome contains a positive-sense single-stranded RNA molecule, and it is classified into 8 genotypes and 87 subtypes. Globally, over 350,000 people die from liver cirrhosis and hepatocellular carcinoma caused by HCV each year. Here, the genotype distribution of HCV was estimated in the population in Cheonan, Korea using Sanger sequencing. In addition, the correlation between HCV RNA level and genotype was assessed using real-time polymerase chain reaction (PCR); similarly, the correlation of HCV RNA level with isolation year (2007-2016) was determined using 463 consecutive serum samples obtained from patients at Dankook University Hospital, Cheonan, Korea. In 2007, genotype 1b (54.2%) was predominant, followed by genotypes 2a (41.7%), 1a (2.1%) and 3a (2.1%); whereas in 2016, the predominant genotype was 2a (49.0%), followed by genotypes 1b (46.9%), 3b (2%), and 4a (2%). Neither age nor sex was correlated with HCV genotype. Furthermore, the mean HCV RNA level decreased significantly from 2012 to 2016 (p < 0.05). However, no significant correlations between genotype and HCV RNA level were found. Overall, the findings revealed that genotypes 2a and 1b were the most common in Cheonan, and the prevalence of HCV genotype 1b tended to decrease over the past decade.

키워드

참고문헌

  1. World Health Organization. 2017. Global Hepatitis Report 2017. Geneva: World Health Organization, 2017.
  2. Kim DY, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, et al. 2013. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int. 33: 586-594. https://doi.org/10.1111/liv.12108
  3. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362. https://doi.org/10.1126/science.2523562
  4. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. 2005. Virus taxonomy: VIIIth report of the International Committee on Taxonomy of Viruses. Academic Press, Cambridge, USA.
  5. Borgia SM, Hedskog C, Parhy B, Hyland RH, Stamm LM, Brainard DM, et al. 2018. Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. J. Infect. Dis. 218: 1722-1729. https://doi.org/10.1093/infdis/jiy401
  6. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59: 318-327. https://doi.org/10.1002/hep.26744
  7. Simmonds P. 1997. Clinical relevance of hepatitis C virus genotypes. Gut 40: 291.
  8. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. 2015. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61: 77-87. https://doi.org/10.1002/hep.27259
  9. Kim BH, Park J-W. 2018. Epidemiology of liver cancer in South Korea. Clin. Mol. Hepatol. 24: 1-9. https://doi.org/10.3350/cmh.2017.0112
  10. Petruzziello A, Marigliano S, Loquercio G, Coppola N, Piccirillo M, Leongito M, et al. 2017. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infect. Agents Cancer 12: 52.
  11. Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. 2009. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J. Hepatol. 50: 1142-1154. https://doi.org/10.1016/j.jhep.2009.01.019
  12. Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. 2007. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 46: 1350-1356. https://doi.org/10.1002/hep.21826
  13. Han CJ, Lee H-S, Kim H-S, Choe JH, Kim CY. 1997. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Korean J. Intern. Med. 12: 21.
  14. Seong MH, Kil H, Kim JY, Lee SS, Jang ES, Kim J-W, et al. 2013. Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6. Clin. Mol. Hepatol. 19: 45-50. https://doi.org/10.3350/cmh.2013.19.1.45
  15. Waheed Y, Siddiq M, Jamil Z, Najmi MH. 2018. Hepatitis elimination by 2030: progress and challenges. World J. Gastroenterol. 24: 4959-4961. https://doi.org/10.3748/wjg.v24.i44.4959
  16. Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. 2017. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J. Transl. Int. Med. 5: 8-17. https://doi.org/10.1515/jtim-2017-0007
  17. Jeong S-H, Jang ES, Choi HY, Kim K-A, Chung W, Ki M. 2017. Current status of hepatitis C virus infection and countermeasures in South Korea. Epidemiol. Health 39: e2017017.
  18. Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, et al. 2008. Distribution of hepatitis C virus genotypes in Jeju Island. Korean J. Hepatol. 14: 28-35. https://doi.org/10.3350/kjhep.2008.14.1.28
  19. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. 2011. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 31: 30-60. https://doi.org/10.1111/j.1478-3231.2011.02539.x
  20. Greene W, Cheong M, Ng V, Yap K. 1995. Prevalence of hepatitis C virus sequence variants in South-East Asia. J. Gen. Virol. 76: 211-215. https://doi.org/10.1099/0022-1317-76-1-211
  21. Li C, Yuan M, Lu L, Lu T, Xia W, Pham VH, et al. 2014. The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology 468: 197-206. https://doi.org/10.1016/j.virol.2014.07.026
  22. Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al. 2015. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PLoS One 10: e0126764.
  23. Nouhin J, Iwamoto M, Prak S, Dousset J-P, Phon K, Heng S, et al. 2019. Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017. Sci. Rep. 9: 7314.
  24. Baatarkhuu O, Kim DY, Ahn SH, Nymadawa P, Dahgwahdorj Y, Shagdarsuren M, et al. 2008. Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study. Liver Int. 28: 1389-1395. https://doi.org/10.1111/j.1478-3231.2008.01820.x
  25. Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. 2017. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg. Microbes Infect. 6: e95.
  26. Toyoda H, Kumada T, Takaguchi K, Shimada N, Tanaka J. 2014. Changes in hepatitis C virus genotype distribution in Japan. Epidemiol. Infect. 142: 2624-2628. https://doi.org/10.1017/S0950268814000478
  27. Lee C-M, Lu S-N, Hung C-H, Tung W-C, Wang J-H, Tung H-D, et al. 2006. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans. R Soc. Trop. Med. Hyg. 100: 767-774. https://doi.org/10.1016/j.trstmh.2005.10.008
  28. Assih M, Ouattara AK, Diarra B, Yonli AT, Compaore TR, ObiriYeboah D, et al. 2018. Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018. World J. Hepatol. 10: 807-821. https://doi.org/10.4254/wjh.v10.i11.807
  29. Ho S-H, Ng K-P, Kaur H, Goh K-L. 2015. Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia. Hepatobiliary Pancreat. Dis. Int. 14: 281-286. https://doi.org/10.1016/S1499-3872(15)60363-0
  30. Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, et al. 2010. Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J. Med. Virol. 82: 257-262. https://doi.org/10.1002/jmv.21680
  31. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, et al. 2009. Genetic history of hepatitis C virus in East Asia. J. Virol. 83: 1071.
  32. Chao D, Abe K, Nguyen M. 2011. Systematic review: epidemiology of hepatitis C genotype 6 and its management. Aliment Pharmacol. Ther. 34: 286-296. https://doi.org/10.1111/j.1365-2036.2011.04714.x
  33. Chung Y-S, Choi J-Y, Han MG, Park KR, Park S-J, Lee H, et al. 2018. A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea. J. Clin. Virol. 106: 53-57. https://doi.org/10.1016/j.jcv.2018.07.006
  34. Kan T, Hashimoto S, Kawabe N, Murao M, Nakano T, Shimazaki H, et al. 2016. The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay. J. Gastroenterol. 51: 63-70. https://doi.org/10.1007/s00535-015-1080-1
  35. Hong C-M, Lin Y-Y, Liu C-J, Lai Y-Y, Yeh S-H, Yang H-C, et al. 2021. Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan. Viruses 13: 2294.
  36. Wyles D, Luetkemeyer A. 2017. Understanding hepatitis C virus drug resistance: clinical implications for current and future regimens. Top. Antivir. Med. 25: 103-109.